Your browser doesn't support javascript.
loading
Understanding potential barriers and enablers to a perioperative early phase cell therapy trial.
Foster, Madison; Fergusson, Dean A; Hunniford, Victoria; Cardenas, Analyssa; Castillo, Gisell; Yaworsky, Judith; Mazer, C David; Devereaux, P J; McIsaac, Daniel I; Stewart, Duncan J; Presseau, Justin; Lalu, Manoj M.
Afiliación
  • Foster M; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Fergusson DA; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
  • Hunniford V; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Cardenas A; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Castillo G; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Yaworsky J; Patient Partner, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Mazer CD; Department of Anesthesiology and Pain Management, University of Toronto, Toronto, Canada; Department of Physiology, University of Toronto, Toronto, Canada.
  • Devereaux PJ; Population Health Research Institute, Hamilton Health Sciences, Hamilton, Canada.
  • McIsaac DI; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada; Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Canada.
  • Stewart DJ; Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada.
  • Presseau J; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada; School of Psychology, University of Ottawa, Ottawa, Canada.
  • Lalu MM; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Canada; Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, Canada; Department of Cellular and Molecular Medicine, U
Cytotherapy ; 24(6): 629-638, 2022 06.
Article en En | MEDLINE | ID: mdl-35396169

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médicos Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Médicos Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Cytotherapy Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido